跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LETYBO - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
LETYBO
Authorized
STANDARD
LETYBO
hugel canada inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
4ee82cdd93071497
Company
hugel canada inc.
Type
Standard
Approval Details
Approval Id
4ee82cdd93071497
Drug Approval Canada Name
LETYBO
Product Name
LETYBO
Status
Marketed
Status Date
2024-11-08
Original Market Date
2023-06-20
Din
02528142
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intramuscular
Schedule
Schedule D , Prescription
Ahfs
12:20.20.24
Atc Original
M03AX01 BOTULINUM TOXIN
Atc Name
m 03 ax 01
Aig Number
0163821002
Company Name
hugel canada inc.
Company Address
SUITE 100, 180 John Street, Toronto, Ontario, Canada, M5T 1X5
Active Ingredients
LETIBOTULINUMTOXINA
100 UNIT / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
4ee82cdd93071497
Type
Standard
Back to Health Canada Approvals